tirzepatide surmount-1 weight loss percent 72 weeks for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Adults with obesity using tirzepatide

Effect of glucagon-like peptide-1 receptor agonists on renal function: A meta-analysis of randomized controlled trials

Results from clinical trials do suggest the theory has some merit

It has done absolutely NOTHING for me for weight loss, one person reported

"Conformational changes on substrate binding to methylmalonyl CoA mutase and new insights into the free radical mechanism"

Microcirculation Animal studies suggest that GLP-1R agonists enhance microvascular function and myocardial perfusion

One such treatment is Semaglutide GLP-1, known under brand names like Wegovy and Ozempic, which has gained recognition for its effectiveness in weight loss